What to Know About Pitocin Errors

Pitocin is a brand name for synthetic oxytocin, a medication used to start labor or strengthen contractions that have already begun. When questions arise about how it was ordered, prepared, dosed, monitored, or stopped, this page can help families understand what may have happened and what options may be available.

What is a Pitocin error?

Pitocin causes the uterus to contract. During labor induction or augmentation, it is generally given through an intravenous infusion so the care team can adjust the rate based on the mother’s response, the contraction pattern, the baby’s heart rate, and the progress of labor. When used appropriately, Pitocin can be an important and effective part of obstetric care.

A Pitocin error is not a medical diagnosis. It is a term used to describe a potentially preventable problem in deciding whether to use the medication, preparing or administering it, monitoring the mother and baby, or responding to signs that the contractions or fetal heart rate have become concerning.

Individual responses to oxytocin vary. Even when the medication is properly administered and supervised, some patients can develop overly strong or frequent contractions. For that reason, a complication or birth injury does not by itself prove that a Pitocin error occurred. The complete labor record must be reviewed to understand whether the care was reasonable under the circumstances.

Warning signs and possible complications

Because Pitocin affects the frequency and strength of uterine contractions, the care team should closely evaluate uterine activity and the fetal heart rate throughout the infusion. Warning signs or complications that may require prompt assessment include:

• Contractions that are too frequent, unusually long, excessively strong, or separated by too little rest
• An abnormally elevated resting uterine tone between contractions
• Recurrent fetal heart rate decelerations, fetal bradycardia, or other concerning changes on the fetal monitor
• Signs that the baby may not be tolerating labor, including evidence of fetal hypoxia or acidosis
• Sudden severe abdominal pain, vaginal bleeding, maternal instability, or other signs of a rare obstetric emergency such as uterine rupture
• A newborn who requires significant resuscitation or is admitted to the neonatal intensive care unit
• Newborn seizures, abnormal muscle tone, difficulty breathing or feeding, decreased alertness, or a diagnosis of hypoxic-ischemic encephalopathy

These findings can have many causes and are not specific to Pitocin. Determining whether the medication contributed to an injury requires review of the dosage record, contraction pattern, fetal heart rate tracing, labor progress, delivery timeline, and newborn evaluation.

What can contribute to Pitocin errors?

Pitocin is a high-alert medication that requires individualized dosing, accurate infusion control, continuous observation, and timely communication among nurses, obstetric providers, and other members of the labor and delivery team. Potential problems can include:

• Starting Pitocin without adequately evaluating whether induction or augmentation is appropriate for the mother and baby
• Using Pitocin when a contraindication or obstetric emergency favors another course of care
• Preparing the wrong concentration or programming the infusion pump incorrectly
• Beginning at an inappropriate rate or increasing the dose too quickly for the clinical situation
• Failing to individualize the dose based on the contraction pattern, fetal response, and progress of labor
• Failing to continuously monitor uterine activity and the fetal heart rate during the infusion
• Misinterpreting or overlooking uterine tachysystole, excessive uterine tone, or concerning fetal heart rate changes
• Failing to reduce or stop the infusion and evaluate the mother and baby when warning signs develop
• Delaying escalation to an obstetric provider or delaying an operative delivery when the fetal status does not improve
• Communication, documentation, or handoff failures that prevent the care team from responding appropriately

Not every difficult induction, prolonged labor, or fetal heart rate abnormality results from a medication error. The question is whether the team selected, dosed, monitored, and responded to Pitocin in a manner consistent with the applicable standard of care.

When a Pitocin error may be medical malpractice

Not every use of Pitocin, labor complication, or birth injury is medical malpractice. Some patients develop excessive contractions or fetal heart rate changes despite appropriate dosing and monitoring, and a baby may experience distress for reasons unrelated to the medication. A claim generally requires evidence that a healthcare provider failed to meet the applicable standard of care and that this failure caused harm. Circumstances that may point to negligence include:

• Administering Pitocin without an appropriate clinical indication or despite a contraindication
• Using the wrong concentration, infusion rate, or pump setting
• Increasing the dose without allowing adequate time to assess the mother’s and baby’s response
• Failing to adequately monitor the contraction pattern, resting uterine tone, or fetal heart rate
• Failing to recognize uterine tachysystole, uterine hypertonicity, or a concerning fetal heart rate tracing
• Continuing the infusion despite signs of uterine hyperactivity or fetal intolerance of labor
• Failing to promptly reduce or stop Pitocin and take appropriate corrective measures
• Failing to notify the responsible physician, escalate care, or move toward timely delivery when the fetal condition does not improve
• Failing to document the dosage, monitoring findings, provider notifications, or response to treatment

Wais, Vogelstein, Forman, Koch & Norman, LLC works with qualified medical experts to review the Pitocin administration record, fetal heart rate tracings, contraction data, nursing notes, provider decisions, delivery timeline, and newborn records to determine whether the standard of care may have been breached and whether that breach caused harm.

Treatment and long-term outlook

When Pitocin is associated with excessive uterine activity or a concerning fetal heart rate pattern, the immediate response depends on the clinical situation. The care team may reduce or stop the infusion, reposition the mother, support blood pressure and oxygenation when indicated, provide intravenous fluids or medication, reassess the mother and baby, and prepare for operative delivery if the fetal condition does not improve.

After birth, a baby who shows signs of oxygen deprivation or neurologic injury may need resuscitation, neonatal intensive care, blood testing, neurologic examinations, seizure monitoring, brain imaging, and treatment tailored to the diagnosis. Eligible newborns with moderate to severe hypoxic-ischemic encephalopathy may be evaluated for therapeutic hypothermia, also called brain cooling, to help limit additional brain injury.

The long-term outlook depends on the nature and severity of the injury, how long the baby experienced reduced oxygen or blood flow, and how quickly effective treatment began. Some children recover without ongoing problems, while others may need follow-up with neurology, developmental specialists, physical therapy, occupational therapy, speech therapy, educational support, or long-term medical care.